Abstract
Cancer/testis (CT) antigens are proteins aberrantly overexpressed in various tumorigenic cells, but they can also be normally expressed in the mammalian germline. Most CT antigens are highly immunogenic and known to be involved in cancer cell proliferation and tumor metastasis. A recent genome-wide analysis systematically identified CT antigen expression in 19 cancer types, significantly expanding the repertoire of CT antigens by 5-fold, from over 200 to approximately 1000. However, their function and regulation in tumorigenesis remain poorly understood. The shared functional characteristics between germ cells and cancer cells, if methodically defined, offer a unique gateway to understanding the regulation of CT antigens in cancers by studying gametogenesis. Nonetheless, such studies also provide insightful information on the role of CT antigens in spermatogenesis. Herein, we analyzed publicly available next generation sequencing datasets generated from normal adult testes in rodents, primordial germ cells and cancer samples across a series of published studies and databases. Based on these analyses, we report that a subset of CT antigens belonged to the core fitness gene family. Furthermore, super-enhancers both in normal testes and various cancers controlled specific CT antigens. We found that DNA methylation of CT antigens, such as TEX101 and TAF7L, was inversely correlated with their expression in both normal primordial germ cells and various cancers, which was mediated at least partly by DNA methyltransferase1 (DNMT1). By analyzing data from a testis knockout model, we showed that TAF7L could further influence the expression of additional CT antigens, which also held true in tumors. These findings not only confirmed the previous notion that CT antigens regulate cancer dynamics, but also showed that understanding the regulation of CT antigens during gametogenesis can offer new insights for cancer research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ribas, A., Butterfield, L. H., Glaspy, J. A., & Economou, J. S. (2003). Current developments in cancer vaccines and cellular immunotherapy. Journal of Clinical Oncology, 21, 2415–2432.
Rosenberg, S. A., Yang, J. C., & Restifo, N. P. (2004). Cancer immunotherapy: Moving beyond current vaccines. Nature Medicine, 10, 909–915.
Tang, E. I., Robinson, C. L., Chong, C. N., Chen, S., & Cheng, C. Y. (2018). A look into the testis as a reservoir for HIV an ZIKV - A reproductive biologist’s perspective. In C. Y. Cheng (Ed.), Spermatogenesis: Biology and clinical implications (pp. 183–190). CRC Press/Taylor & Francis Group.
Meinhardt, A., & Hedger, M. P. (2011). Immunological, paracrine and endocrine aspects of testicular immune privilege. Molecular and Cellular Endocrinology, 335, 60–68.
Cheng, Y. H., Wong, E. W., & Cheng, C. Y. (2011). Cancer/testis (CT) antigens, carcinogenesis and spermatogenesis. Spermatogenesis, 1, 209–220.
Simpson, A. J., Caballero, O. L., Jungbluth, A., Chen, Y. T., & Old, L. J. (2005). Cancer/testis antigens, gametogenesis and cancer. Nature Reviews. Cancer, 5, 615–625.
van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., & Boon, T. (1991). A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science, 254, 1643–1647.
Almeida, L. G., Sakabe, N. J., deOliveira, A. R., Silva, M. C., Mundstein, A. S., Cohen, T., Chen, Y. T., Chua, R., Gurung, S., Gnjatic, S., Jungbluth, A. A., Caballero, O. L., Bairoch, A., Kiesler, E., White, S. L., Simpson, A. J., Old, L. J., Camargo, A. A., & Vasconcelos, A. T. (2009). CTdatabase: A knowledge-base of high-throughput and curated data on cancer-testis antigens. Nucleic Acids Research, 37, D816–D819.
Gjerstorff, M. F., Andersen, M. H., & Ditzel, H. J. (2015). Oncogenic cancer/testis antigens: Prime candidates for immunotherapy. Oncotarget, 6, 15772–15787.
Vansteenkiste, J. F., Cho, B. C., Vanakesa, T., De Pas, T., Zielinski, M., Kim, M. S., Jassem, J., Yoshimura, M., Dahabreh, J., Nakayama, H., Havel, L., Kondo, H., Mitsudomi, T., Zarogoulidis, K., Gladkov, O. A., Udud, K., Tada, H., Hoffman, H., Bugge, A., … Altorki, N. (2016). Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): A randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Oncology, 17, 822–835.
Ogi, C., & Aruga, A. (2013). Immunological monitoring of anticancer vaccines in clinical trials. Oncoimmunology, 2, e26012.
Old, L. J. (2001). Cancer/testis (CT) antigens - A new link between gametogenesis and cancer. Cancer Immunity, 1, 1.
Wang, C., Gu, Y., Zhang, K., Xie, K., Zhu, M., Dai, N., Jiang, Y., Guo, X., Liu, M., Dai, J., Wu, L., Jin, G., Ma, H., Jiang, T., Yin, R., Xia, Y., Liu, L., Wang, S., Shen, B., … Hu, Z. (2016). Systematic identification of genes with a cancer-testis expression pattern in 19 cancer types. Nature Communications, 7, 10499.
Pertea, M., Kim, D., Pertea, G. M., Leek, J. T., & Salzberg, S. L. (2016). Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown. Nature Protocols, 11, 1650–1667.
Kim, D., Langmead, B., & Salzberg, S. L. (2015). HISAT: A fast spliced aligner with low memory requirements. Nature Methods, 12, 357–360.
Pertea, M., Pertea, G. M., Antonescu, C. M., Chang, T. C., Mendell, J. T., & Salzberg, S. L. (2015). StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nature Biotechnology, 33, 290–295.
Frazee, A. C., Pertea, G., Jaffe, A. E., Langmead, B., Salzberg, S. L., & Leek, J. T. (2015). Ballgown bridges the gap between transcriptome assembly and expression analysis. Nature Biotechnology, 33, 243–246.
Langmead, B., & Salzberg, S. L. (2012). Fast gapped-read alignment with Bowtie 2. Nature Methods, 9, 357–359.
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., & Liu, X. S. (2008). Model-based analysis of ChIP-Seq (MACS). Genome Biology, 9, R137.
Yu, G., Wang, L. G., & He, Q. Y. (2015). ChIPseeker: An R/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics, 31, 2382–2383.
Thorvaldsdottir, H., Robinson, J. T., & Mesirov, J. P. (2013). Integrative Genomics Viewer (IGV): High-performance genomics data visualization and exploration. Briefings in Bioinformatics, 14, 178–192.
Robinson, J. T., Thorvaldsdottir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011). Integrative genomics viewer. Nature Biotechnology, 29, 24–26.
Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J., Lin, C. Y., Kagey, M. H., Rahl, P. B., Lee, T. I., & Young, R. A. (2013). Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell, 153, 307–319.
Loven, J., Hoke, H. A., Lin, C. Y., Lau, A., Orlando, D. A., Vakoc, C. R., Bradner, J. E., Lee, T. I., & Young, R. A. (2013). Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell, 153, 320–334.
Hart, T., Chandrashekhar, M., Aregger, M., Steinhart, Z., Brown, K. R., MacLeod, G., Mis, M., Zimmermann, M., Fradet-Turcotte, A., Sun, S., Mero, P., Dirks, P., Sidhu, S., Roth, F. P., Rissland, O. S., Durocher, D., Angers, S., & Moffat, J. (2015). High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities. Cell, 163, 1515–1526.
Perez-Rico, Y. A., Boeva, V., Mallory, A. C., Bitetti, A., Majello, S., Barillot, E., & Shkumatava, A. (2017). Comparative analyses of super-enhancers reveal conserved elements in vertebrate genomes. Genome Research, 27, 259–268.
Hnisz, D., Abraham, B. J., Lee, T. I., Lau, A., Saint-Andre, V., Sigova, A. A., Hoke, H. A., & Young, R. A. (2013). Super-enhancers in the control of cell identity and disease. Cell, 155, 934–947.
Kufer, T. A., Sillje, H. H., Korner, R., Gruss, O. J., Meraldi, P., & Nigg, E. A. (2002). Human TPX2 is required for targeting Aurora-A kinase to the spindle. The Journal of Cell Biology, 158, 617–623.
Gruss, O. J., Wittmann, M., Yokoyama, H., Pepperkok, R., Kufer, T., Sillje, H., Karsenti, E., Mattaj, I. W., & Vernos, I. (2002). Chromosome-induced microtubule assembly mediated by TPX2 is required for spindle formation in HeLa cells. Nature Cell Biology, 4, 871–879.
Gruss, O. J., Carazo-Salas, R. E., Schatz, C. A., Guarguaglini, G., Kast, J., Wilm, M., Le Bot, N., Vernos, I., Karsenti, E., & Mattaj, I. W. (2001). Ran induces spindle assembly by reversing the inhibitory effect of importin alpha on TPX2 activity. Cell, 104, 83–93.
Petry, S., Groen, A. C., Ishihara, K., Mitchison, T. J., & Vale, R. D. (2013). Branching microtubule nucleation in Xenopus egg extracts mediated by augmin and TPX2. Cell, 152, 768–777.
Guo, F., Yan, L., Guo, H., Li, L., Hu, B., Zhao, Y., Yong, J., Hu, Y., Wang, X., Wei, Y., Wang, W., Li, R., Yan, J., Zhi, X., Zhang, Y., Jin, H., Zhang, W., Hou, Y., Zhu, P., … Qiao, J. (2015). The transcriptome and DNA methylome landscapes of human primordial germ cells. Cell, 161, 1437–1452.
Yamaguchi, S., Hong, K., Liu, R., Shen, L., Inoue, A., Diep, D., Zhang, K., & Zhang, Y. (2013). Tet1 controls meiosis by regulating meiotic gene expression. Nature, 492, 443–447.
Yamaguchi, S., Hong, K., Liu, R., Inoue, A., Shen, L., Zhang, K., & Zhang, Y. (2013). Dynamics of 5-methylcytosine and 5-hydroxymethylcytosine during germ cell reprogramming. Cell Research, 23, 329–339.
Soumillon, M., Necsulea, A., Weier, M., Brawand, D., Zhang, X., Gu, H., Barthes, P., Kokkinaki, M., Nef, S., Gnirke, A., Dym, M., de Massy, B., Mikkelsen, T. S., & Kaessmann, H. (2013). Cellular source and mechanisms of high transcriptome complexity in the mammalian testis. Cell Reports, 3, 2179–2190.
Hunter, A. W., Caplow, M., Coy, D. L., Hancock, W. O., Diez, S., Wordeman, L., & Howard, J. (2003). The kinesin-related protein MCAK is a microtubule depolymerase that forms an ATP-hydrolyzing complex at microtubule ends. Molecular Cell, 11, 445–457.
Ganem, N. J., & Compton, D. A. (2004). The KinI kinesin Kif2a is required for bipolar spindle assembly through a functional relationship with MCAK. The Journal of Cell Biology, 166, 473–478.
Gnjatic, S., Cao, Y., Reichelt, U., Yekebas, E. F., Nolker, C., Marx, A. H., Erbersdobler, A., Nishikawa, H., Hildebrandt, Y., Bartels, K., Horn, C., Stahl, T., Gout, I., Filonenko, V., Ling, K. L., Cerundolo, V., Luetkens, T., Ritter, G., Friedrichs, K., … Atanackovic, D. (2010). NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer. International Journal of Cancer, 127, 381–393.
Bie, L., Zhao, G., Wang, Y. P., & Zhang, B. (2012). Kinesin family member 2C (KIF2C/MCAK) is a novel marker for prognosis in human gliomas. Clinical Neurology and Neurosurgery, 114, 356–360.
Smith, J. S., Tachibana, I., Pohl, U., Lee, H. K., Thanarajasingam, U., Portier, B. P., Ueki, K., Ramaswamy, S., Billings, S. J., Mohrenweiser, H. W., Louis, D. N., & Jenkins, R. B. (2000). A transcript map of the chromosome 19q-arm glioma tumor suppressor region. Genomics, 64, 44–50.
Nakamura, Y., Dagio, Y., & Togashi, A. (2009). Syngr4 for target genes of cancer therapy and diagnosis USA.
Smith, Z. D., & Meissner, A. (2013). DNA methylation: Roles in mammalian development. Nature Reviews. Genetics, 14, 204–220.
Schubeler, D. (2015). Function and information content of DNA methylation. Nature, 517, 321–326.
Heyn, H., Vidal, E., Ferreira, H. J., Vizoso, M., Sayols, S., Gomez, A., Moran, S., Boque-Sastre, R., Guil, S., Martinez-Cardus, A., Lin, C. Y., Royo, R., Sanchez-Mut, J. V., Martinez, R., Gut, M., Torrents, D., Orozco, M., Gut, I., Young, R. A., & Esteller, M. (2016). Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer. Genome Biology, 17, 11.
Baubec, T., & Schubeler, D. (2014). Genomic patterns and context specific interpretation of DNA methylation. Current Opinion in Genetics & Development, 25, 85–92.
Milekic, M. H., Xin, Y., O’Donnell, A., Kumar, K. K., Bradley-Moore, M., Malaspina, D., Moore, H., Brunner, D., Ge, Y., Edwards, J., Paul, S., Haghighi, F. G., & Gingrich, J. A. (2015). Age-related sperm DNA methylation changes are transmitted to offspring and associated with abnormal behavior and dysregulated gene expression. Molecular Psychiatry, 20, 995–1001.
Messerschmidt, D. M., Knowles, B. B., & Solter, D. (2014). DNA methylation dynamics during epigenetic reprogramming in the germline and preimplantation embryos. Genes & Development, 28, 812–828.
Seisenberger, S., Andrews, S., Krueger, F., Arand, J., Walter, J., Santos, F., Popp, C., Thienpont, B., Dean, W., & Reik, W. (2012). The dynamics of genome-wide DNA methylation reprogramming in mouse primordial germ cells. Molecular Cell, 48, 849–862.
Kagiwada, S., Kurimoto, K., Hirota, T., Yamaji, M., & Saitou, M. (2013). Replication-coupled passive DNA demethylation for the erasure of genome imprints in mice. The EMBO Journal, 32, 340–353.
Maatouk, D. M., Kellam, L. D., Mann, M. R., Lei, H., Li, E., Bartolomei, M. S., & Resnick, J. L. (2006). DNA methylation is a primary mechanism for silencing postmigratory primordial germ cell genes in both germ cell and somatic cell lineages. Development, 133, 3411–3418.
Hargan-Calvopina, J., Taylor, S., Cook, H., Hu, Z., Lee, S. A., Yen, M. R., Chiang, Y. S., Chen, P. Y., & Clark, A. T. (2016). Stage-Specific Demethylation in Primordial Germ Cells Safeguards against Precocious Differentiation. Developmental Cell, 39, 75–86.
Li, W., Guo, X. J., Teng, F., Hou, X. J., Lv, Z., Zhou, S. Y., Bi, Y., Wan, H. F., Feng, C. J., Yuan, Y., Zhao, X. Y., Wang, L., Sha, J. H., & Zhou, Q. (2013). Tex101 is essential for male fertility by affecting sperm migration into the oviduct in mice. Journal of Molecular Cell Biology, 5, 345–347.
Fujihara, Y., Tokuhiro, K., Muro, Y., Kondoh, G., Araki, Y., Ikawa, M., & Okabe, M. (2013). Expression of TEX101, regulated by ACE, is essential for the production of fertile mouse spermatozoa. Proceedings of the National Academy of Sciences of the United States of America, 110, 8111–8116.
Ghafouri-Fard, S., Abbasi, A., Moslehi, H., Faramarzi, N., Taba Taba Vakili, S., Mobasheri, M. B., & Modarressi, M. H. (2009). Elevated expression levels of testis-specific genes TEX101 and SPATA19 in basal cell carcinoma and their correlation with clinical and pathological features. The British Journal of Dermatology, 162, 772–779.
Dianatpour, M., Mehdipour, P., Nayernia, K., Mobasheri, M. B., Ghafouri-Fard, S., Savad, S., & Modarressi, M. H. (2012). Expression of testis specific genes TSGA10, TEX101 and ODF3 in breast cancer. Iranian Red Crescent Medical Journal, 14, 722–726.
Mobasheri, M. B., Shirkoohi, R., Zendehdel, K., Jahanzad, I., Talebi, S., Afsharpad, M., & Modarressi, M. H. (2015). Transcriptome analysis of the cancer/testis genes, DAZ1, AURKC, and TEX101, in breast tumors and six breast cancer cell lines. Tumour Biology, 36, 8201–8206.
Yoshitake, H., Yokoi, H., Ishikawa, H., Maruyama, M., Endo, S., Nojima, M., Yoshida, K., Yoshikawa, H., Suzuki, F., Takamori, K., Fujiwara, H., & Araki, Y. (2012). Overexpression of TEX101, a potential novel cancer marker, in head and neck squamous cell carcinoma. Cancer Biomarkers, 12, 141–148.
Heiser, L. M., Sadanandam, A., Kuo, W. L., Benz, S. C., Goldstein, T. C., Ng, S., Gibb, W. J., Wang, N. J., Ziyad, S., Tong, F., Bayani, N., Hu, Z., Billig, J. I., Dueregger, A., Lewis, S., Jakkula, L., Korkola, J. E., Durinck, S., Pepin, F., … Spellman, P. T. (2012). Subtype and pathway specific responses to anticancer compounds in breast cancer. Proceedings of the National Academy of Sciences of the United States of America, 109, 2724–2729.
Pointud, J. C., Mengus, G., Brancorsini, S., Monaco, L., Parvinen, M., Sassone-Corsi, P., & Davidson, I. (2003). The intracellular localisation of TAF7L, a paralogue of transcription factor TFIID subunit TAF7, is developmentally regulated during male germ-cell differentiation. Journal of Cell Science, 116, 1847–1858.
Kimmins, S., Kotaja, N., Davidson, I., & Sassone-Corsi, P. (2004). Testis-specific transcription mechanisms promoting male germ-cell differentiation. Reproduction, 128, 5–12.
Cheng, Y., Buffone, M. G., Kouadio, M., Goodheart, M., Page, D. C., Gerton, G. L., Davidson, I., & Wang, P. J. (2007). Abnormal sperm in mice lacking the Taf7l gene. Molecular and Cellular Biology, 27, 2582–2589.
Yazarloo, F., Shirkoohi, R., Mobasheri, M. B., Emami, A., & Modarressi, M. H. (2013). Expression analysis of four testis-specific genes AURKC, OIP5, PIWIL2 and TAF7L in acute myeloid leukemia: A gender-dependent expression pattern. Medical Oncology, 30, 368.
Zhou, H., Grubisic, I., Zheng, K., He, Y., Wang, P. J., Kaplan, T., & Tjian, R. (2013). Taf7l cooperates with Trf2 to regulate spermiogenesis. Proceedings of the National Academy of Sciences of the United States of America, 110, 16886–16891.
Dong, X. Y., Su, Y. R., Qian, X. P., Yang, X. A., Pang, X. W., Wu, H. Y., & Chen, W. F. (2003). Identification of two novel CT antigens and their capacity to elicit antibody response in hepatocellular carcinoma patients. British Journal of Cancer, 89, 291–297.
Doghman-Bouguerra, M., Granatiero, V., Sbiera, S., Sbiera, I., Lacas-Gervais, S., Brau, F., Fassnacht, M., Rizzuto, R., & Lalli, E. (2016). FATE1 antagonizes calcium- and drug-induced apoptosis by uncoupling ER and mitochondria. EMBO Reports, 17, 1264–1280.
da Silva, V. L., Fonseca, A. F., Fonseca, M., da Silva, T. E., Coelho, A. C., Kroll, J. E., de Souza, J. E. S., Stransky, B., de Souza, G. A., & de Souza, S. J. (2017). Genome-wide identification of cancer/testis genes and their association with prognosis in a pan-cancer analysis. Oncotarget, 8, 92966–92977.
Old, L. J. (2007). Cancer is a somatic cell pregnancy. Cancer Immunity, 7, 19.
Mansour, M. R., Abraham, B. J., Anders, L., Berezovskaya, A., Gutierrez, A., Durbin, A. D., Etchin, J., Lawton, L., Sallan, S. E., Silverman, L. B., Loh, M. L., Hunger, S. P., Sanda, T., Young, R. A., & Look, A. T. (2014). Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. Science, 346, 1373–1377.
Chapuy, B., McKeown, M. R., Lin, C. Y., Monti, S., Roemer, M. G., Qi, J., Rahl, P. B., Sun, H. H., Yeda, K. T., Doench, J. G., Reichert, E., Kung, A. L., Rodig, S. J., Young, R. A., Shipp, M. A., & Bradner, J. E. (2013). Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma. Cancer Cell, 24, 777–790.
Chipumuro, E., Marco, E., Christensen, C. L., Kwiatkowski, N., Zhang, T., Hatheway, C. M., Abraham, B. J., Sharma, B., Yeung, C., Altabef, A., Perez-Atayde, A., Wong, K. K., Yuan, G. C., Gray, N. S., Young, R. A., & George, R. E. (2014). CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer. Cell, 159, 1126–1139.
Kulis, M., & Esteller, M. (2010). DNA methylation and cancer. Advances in Genetics, 70, 27–56.
Van Tongelen, A., Loriot, A., & De Smet, C. (2017). Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes. Cancer Letters, 396, 130–137.
De Smet, C., & Loriot, A. (2013). DNA hypomethylation and activation of germline-specific genes in cancer. Advances in Experimental Medicine and Biology, 754, 149–166.
Shichijio, S., Yamada, A., Sagawa, K., Iwanmoto, O., Sakata, M., Nagai, K., & Itoh, K. (1996). Induction of MAGE genes in lymphoid cells by the demethylating agent 5-aza-2′-deoxycytidine. Japanese Journal of Cancer Research, 87, 751–756.
Milutinovic, S., Zhuang, Q., Niveleau, A., & Szyf, M. (2003). Epigenomic stress response. Knockdown of DNA methyltransferase 1 triggers an intra-S-phase arrest of DNA replication and induction of stress response genes. The Journal of Biological Chemistry, 278, 14985–14995.
James, S. R., Link, P. A., & Karpf, A. R. (2006). Epigenetic regulation of X-linked cancer/germline antigen genes by DNMT1 and DNMT3b. Oncogene, 25, 6975–6985.
De Smet, C., Lurquin, C., Lethe, B., Martelange, V., & Boon, T. (1999). DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Molecular and Cellular Biology, 19, 7327–7335.
Hoffmann, M. J., Muller, M., Engers, R., & Schulz, W. A. (2006). Epigenetic control of CTCFL/BORIS and OCT4 expression in urogenital malignancies. Biochemical Pharmacology, 72, 1577–1588.
Woloszynska-Read, A., James, S. R., Link, P. A., Yu, J., Odunsi, K., & Karpf, A. R. (2007). DNA methylation-dependent regulation of BORIS/CTCFL expression in ovarian cancer. Cancer Immunity, 7, 21.
Hong, J. A., Kang, Y., Abdullaev, Z., Flanagan, P. T., Pack, S. D., Fischette, M. R., Adnani, M. T., Loukinov, D. I., Vatolin, S., Risinger, J. I., Custer, M., Chen, G. A., Zhao, M., Nguyen, D. M., Barrett, J. C., Lobanenkov, V. V., & Schrump, D. S. (2005). Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells. Cancer Research, 65, 7763–7774.
Acknowledgements
This work was supported in part by a grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD056034 to C.Y.C.); H.C. was supported by the S.Y. Law Memorial Fellowship and the F. Lau Memorial Fellowship
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Chen, H., Jiang, Y., Mruk, D.D., Cheng, C.Y. (2021). Unraveling the Regulation of Cancer/Testis Antigens in Tumorigenesis Through an Analysis of Normal Germ Cell Development in Rodents. In: Cheng, C., Sun, F. (eds) Molecular Mechanisms in Spermatogenesis. Advances in Experimental Medicine and Biology, vol 1381. Springer, Cham. https://doi.org/10.1007/978-3-030-77779-1_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-77779-1_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-77778-4
Online ISBN: 978-3-030-77779-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)